Pharmacoeconomics of Influenza Vaccination for Healthy Working AdultsReviewing the Available Evidence

被引:0
作者
Maarten J. Postma
Paul Jansema
Marianne L. L. van Genugten
Marie-Louise A. Heijnen
Johannes C. Jager
Lolkje T. W. de Jong-van den Berg
机构
[1] University of Groningen Research Institute of Pharmacy (GUIDE/GRIP),Groningen University Institute for Drug Exploration
[2] National Institute of Public Health and the Environment (RIVM),undefined
来源
Drugs | 2002年 / 62卷
关键词
Influenza; Indirect Cost; Influenza Vaccination; Indirect Benefit; Pharmacoeconomic Evaluation;
D O I
暂无
中图分类号
学科分类号
摘要
A favourable pharmacoeconomic profile has been well established for influenza vaccination in the elderly. For employers relevant benefits seem to exist for vaccinating healthy working adults to avert absenteeism and related production losses. From a pharmacoeconomic point of view it is relevant to consider whether societal benefits of vaccination for healthy working adults is worthwhile given the costs of vaccination for the community.
引用
收藏
页码:1013 / 1024
页数:11
相关论文
共 112 条
  • [11] Spaargaren J(1977)A perspective on the significance of pandemic influenza Am J Public Health 67 1063-70
  • [12] Wood SC(1979)Vaccination against influenza: a five-year study in the Post Office J Hyg Camb 83 157-80
  • [13] Nguyen VH(1995)Influenza vaccine for healthy adults? N Engl J Med 14 933-4
  • [14] Schmidt C(2000)Preventing influenza in healthy adults; the evolving story JAMA 284 1699-701
  • [15] Snacken R(1983)Influenza vaccination; cost-effectiveness and public policy JAMA 249 3189-95
  • [16] Szucs TD(1989)Benefits and costs of influenza immunization in the workforce Asian Pacific Hum Res Man 11 87-93
  • [17] Hannoun C(1991)Effectiveness and cost-benefit of an influenza vaccination program for health care workers Can J Infect Dis 2 101-8
  • [18] Schoenbaum SC(1995)the effectiveness of vaccination against influenza in healthy, working adults N Engl J Med 333 889-93
  • [19] McNeil BJ(1996)Sickness absence following a campaign of vaccination against influenza in the workplace Occup Med 46 146-50
  • [20] Kavet J(1996)French economic evaluations of influenza and influenza vaccination Pharmacoeconomics 9 62-6